Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates

Over the years, the increasing acquisition of antibiotic resistance genes has led to the emergence of highly resistant bacterial strains and the loss of standard antibiotics’ efficacy, including β-lactam/β-lactamase inhibitor combinations and the last line carbapenems. <i>Klebsiella pneumoniae...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Emanuela Roscetto, Rosa Bellavita, Rossella Paolillo, Francesco Merlino, Nicola Molfetta, Paolo Grieco, Elisabetta Buommino, Maria Rosaria Catania
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/1ad3760843114b6ebd6ac427c755dd40
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1ad3760843114b6ebd6ac427c755dd40
record_format dspace
spelling oai:doaj.org-article:1ad3760843114b6ebd6ac427c755dd402021-11-25T16:22:37ZAntimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates10.3390/antibiotics101113122079-6382https://doaj.org/article/1ad3760843114b6ebd6ac427c755dd402021-10-01T00:00:00Zhttps://www.mdpi.com/2079-6382/10/11/1312https://doaj.org/toc/2079-6382Over the years, the increasing acquisition of antibiotic resistance genes has led to the emergence of highly resistant bacterial strains and the loss of standard antibiotics’ efficacy, including β-lactam/β-lactamase inhibitor combinations and the last line carbapenems. <i>Klebsiella pneumoniae</i> is considered one of the major exponents of a group of multidrug-resistant ESKAPE pathogens responsible for serious healthcare-associated infections. In this study, we proved the antimicrobial activity of two analogues of Temporin L against twenty carbapenemase-producing <i>K. pneumoniae</i> clinical isolates. According to the antibiotic susceptibility assay, all the <i>K. pneumoniae</i> strains were resistant to at least one other class of antibiotics, in addition to beta-lactams. Peptides <b>1B</b> and <b>C</b> showed activity on all test strains, but the lipidated analogue <b>C</b> expressed the greater antimicrobial properties, with MIC values ranging from 6.25 to 25 µM. Furthermore, the peptide <b>C</b> showed bactericidal activity at MIC values. The results clearly highlight the great potential of antimicrobial peptides both as a new treatment option for difficult-to-treat infections and as a new strategy of drug-resistance control.Emanuela RoscettoRosa BellavitaRossella PaolilloFrancesco MerlinoNicola MolfettaPaolo GriecoElisabetta BuomminoMaria Rosaria CataniaMDPI AGarticle<i>Klebsiella pneumoniae</i>ESKAPEmultidrug resistancecarbapenemaseshealthcare-associated infectionsantimicrobial peptidesTherapeutics. PharmacologyRM1-950ENAntibiotics, Vol 10, Iss 1312, p 1312 (2021)
institution DOAJ
collection DOAJ
language EN
topic <i>Klebsiella pneumoniae</i>
ESKAPE
multidrug resistance
carbapenemases
healthcare-associated infections
antimicrobial peptides
Therapeutics. Pharmacology
RM1-950
spellingShingle <i>Klebsiella pneumoniae</i>
ESKAPE
multidrug resistance
carbapenemases
healthcare-associated infections
antimicrobial peptides
Therapeutics. Pharmacology
RM1-950
Emanuela Roscetto
Rosa Bellavita
Rossella Paolillo
Francesco Merlino
Nicola Molfetta
Paolo Grieco
Elisabetta Buommino
Maria Rosaria Catania
Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
description Over the years, the increasing acquisition of antibiotic resistance genes has led to the emergence of highly resistant bacterial strains and the loss of standard antibiotics’ efficacy, including β-lactam/β-lactamase inhibitor combinations and the last line carbapenems. <i>Klebsiella pneumoniae</i> is considered one of the major exponents of a group of multidrug-resistant ESKAPE pathogens responsible for serious healthcare-associated infections. In this study, we proved the antimicrobial activity of two analogues of Temporin L against twenty carbapenemase-producing <i>K. pneumoniae</i> clinical isolates. According to the antibiotic susceptibility assay, all the <i>K. pneumoniae</i> strains were resistant to at least one other class of antibiotics, in addition to beta-lactams. Peptides <b>1B</b> and <b>C</b> showed activity on all test strains, but the lipidated analogue <b>C</b> expressed the greater antimicrobial properties, with MIC values ranging from 6.25 to 25 µM. Furthermore, the peptide <b>C</b> showed bactericidal activity at MIC values. The results clearly highlight the great potential of antimicrobial peptides both as a new treatment option for difficult-to-treat infections and as a new strategy of drug-resistance control.
format article
author Emanuela Roscetto
Rosa Bellavita
Rossella Paolillo
Francesco Merlino
Nicola Molfetta
Paolo Grieco
Elisabetta Buommino
Maria Rosaria Catania
author_facet Emanuela Roscetto
Rosa Bellavita
Rossella Paolillo
Francesco Merlino
Nicola Molfetta
Paolo Grieco
Elisabetta Buommino
Maria Rosaria Catania
author_sort Emanuela Roscetto
title Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
title_short Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
title_full Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
title_fullStr Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
title_full_unstemmed Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
title_sort antimicrobial activity of a lipidated temporin l analogue against carbapenemase-producing <i>klebsiella pneumoniae</i> clinical isolates
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/1ad3760843114b6ebd6ac427c755dd40
work_keys_str_mv AT emanuelaroscetto antimicrobialactivityofalipidatedtemporinlanalogueagainstcarbapenemaseproducingiklebsiellapneumoniaeiclinicalisolates
AT rosabellavita antimicrobialactivityofalipidatedtemporinlanalogueagainstcarbapenemaseproducingiklebsiellapneumoniaeiclinicalisolates
AT rossellapaolillo antimicrobialactivityofalipidatedtemporinlanalogueagainstcarbapenemaseproducingiklebsiellapneumoniaeiclinicalisolates
AT francescomerlino antimicrobialactivityofalipidatedtemporinlanalogueagainstcarbapenemaseproducingiklebsiellapneumoniaeiclinicalisolates
AT nicolamolfetta antimicrobialactivityofalipidatedtemporinlanalogueagainstcarbapenemaseproducingiklebsiellapneumoniaeiclinicalisolates
AT paologrieco antimicrobialactivityofalipidatedtemporinlanalogueagainstcarbapenemaseproducingiklebsiellapneumoniaeiclinicalisolates
AT elisabettabuommino antimicrobialactivityofalipidatedtemporinlanalogueagainstcarbapenemaseproducingiklebsiellapneumoniaeiclinicalisolates
AT mariarosariacatania antimicrobialactivityofalipidatedtemporinlanalogueagainstcarbapenemaseproducingiklebsiellapneumoniaeiclinicalisolates
_version_ 1718413183907004416